Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: Meaning of the model for end-stage liver disease

被引:46
作者
Cucchetti, Alessandro [1 ]
Ercolani, Giorgio [1 ]
Cescon, Matteo [1 ]
Ravaioli, Matteo [1 ]
Zanello, Matteo [1 ]
Del Gaudio, Massimo [1 ]
Lauro, Augusto [1 ]
Vivarelli, Marco [1 ]
Grazi, Gian Luca [1 ]
Pinna, Antonio Daniele [1 ]
机构
[1] Univ Bologna, Policlin Sant Orsola Malpighi, Dept Surg & Transplantat, I-40138 Bologna, Italy
关键词
D O I
10.1016/j.jamcollsurg.2006.06.018
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Hepatectomy for hepatocellular carcinoma in cirrhosis is followed by an impairment of liver function that can lead to patient death. The model for end-stage liver disease (MELD) is considered an index of hepatic functional reserve, and its assessment on postoperative course may properly identify individuals at risk of liver failure. STUDY DESIGN: Two hundred hepatectomies for hepatocellular carcinoma in cirrhosis were reviewed. Irreversible postoperative liver failure was defined as an impairment of liver function after hepatectomy that led to patient death or required transplantation. The MELD scores at postoperative days (POD) 1, 3, 5, and 7 were calculated and kinetics of changes investigated with t-test; logistic regression was applied to identify predictive variables of postoperative liver failure. RESULTS: Kinetics of postoperative MELD score showed an impairment of liver function between PODs I and 3; 185 patients in whom postoperative liver failure did not develop showed a considerable decrease in MELD score between PODs 3 and 5 (11.9 +/- 2.8 and 10.6 +/- 2.4, respectively, p < 0.001). On the contrary, 15 patients, who experienced the event, showed an increase in MELD score between PODs 3 and 5 (18.2 +/- 3.9 and 18.3 +/- 3.6, respectively; p = 0.845). Multivariate analysis showed preoperative MELD score (p < 0.001), major hepatectomy (p = 0.028), and MELD score increase between PODs 3 and 5 (p = 0.011) as independent predictors of irreversible postoperative liver failure. Scores are reported as mean +/- SD. CONCLUSIONS: Recovery from liver impairment after hepatectomy for hepatocellular carcinoma in cirrhosis starts from POD 3; MELD scores increasing between PODs 3 and 5 may identify patients at risk of liver failure and represents the trigger for beginning intensive treatment or evaluating salvage transplantation.
引用
收藏
页码:670 / 676
页数:7
相关论文
共 24 条
[1]  
[Anonymous], 1964, LIVER PORTAL HYPERTE
[2]   The "50-50 criteria" on postoperative day 5 - An accurate predictor of liver failure and death after hepatectomy [J].
Balzan, S ;
Belghiti, J ;
Farges, O ;
Ogata, S ;
Sauvanet, A ;
Delefosse, D ;
Durand, F .
ANNALS OF SURGERY, 2005, 242 (06) :824-829
[3]  
Beighiti J, 2002, HEPATO-GASTROENTEROL, V49, P41
[4]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[5]  
*COMM INT HEP PANC, IHPBA BRISB 2000 TER, V2, P333
[6]   Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis [J].
Cucchetti, Alessandro ;
Ercolani, Giorgio ;
Vivarelli, Marco ;
Cescon, Matteo ;
Ravaioli, Matteo ;
La Barba, Giuliano ;
Zanello, Matteo ;
Grazi, Gian Luca ;
Pinna, Antonio Daniele .
LIVER TRANSPLANTATION, 2006, 12 (06) :966-971
[7]   The lidocaine (MEGX) test as an index of hepatic function:: Its clinical usefulness in liver surgery [J].
Ercolani, G ;
Grazi, GL ;
Callivà, R ;
Pierangeli, F ;
Cescon, M ;
Cavallari, A ;
Mazziotti, A .
SURGERY, 2000, 127 (04) :464-471
[8]   Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Lam, CM ;
Yuen, WK ;
Yeung, C ;
Wong, J .
ANNALS OF SURGERY, 1999, 229 (03) :322-330
[9]   Risk of major liver resection in patients with underlying chronic liver disease - A reappraisal [J].
Farges, O ;
Malassagne, B ;
Flejou, JF ;
Balzan, S ;
Sauvanet, A ;
Belghiti, J .
ANNALS OF SURGERY, 1999, 229 (02) :210-215
[10]   The new liver allocation system: Moving toward evidence-based transplantation policy [J].
Freeman, RB ;
Wiesner, RH ;
Harper, A ;
McDiarmid, SV ;
Lake, J ;
Edwards, E ;
Merion, R ;
Wolfe, R ;
Turcotte, J ;
Teperman, L .
LIVER TRANSPLANTATION, 2002, 8 (09) :851-858